About Othram
Othram provides forensic DNA testing and identity tools to law enforcement, medical examiners and forensic professionals. Its offerings include Forensic-Grade Genome Sequencing, KinSNP relationship testing, DNASolves and the Othram Swab Kit. Its in-house pipeline covers DNA extraction, enrichment, repair, sequencing and genetic genealogy. It assesses sample feasibility before testing to conserve evidence. KinSNP, mixture deconvolution and DNASolves help generate identification leads. Its accredited laboratory maintains chain of custody, while experienced analysts can testify in court. People may voluntarily add their own DNA profiles to the DNASolves registry for investigative matching.
Othram is based in The Woodlands, Texas, and works with federal partners and law enforcement agencies in almost every state. It supports international investigations and has applied forensic genetic genealogy in thousands of cases involving unidentified remains, missing people and violent crimes. NamUs and the Australian Federal Police's national DNA program use its technology. Its Sorenson Forensics subsidiary adds evidence screening, traditional DNA analysis, consultation and expert testimony. Sorenson retained its Draper, Utah, location, team, accreditation and licensing. David Mittelman is chief executive officer. The company has 70 employees and received $1.32 million across two federal small-business awards.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Nov 6, 2026 | $10,000,000fully sold | 4 | $2.5M | Debt, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Feb 1, 2024 | Feb 15, 2024amended Jun 12, 2025 | $22,099,997of $26.9M target | 9 | $2.4M | Equity, Series C Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 3, 2021 | Sep 15, 2021 | $18,000,000fully sold | 4 | $4.5M | EquityRule 506(b) | Form D ↗ |
| Apr 15, 2020 | May 20, 2020 | $4,603,448of $6.5M target | 7 | $657K | EquityRule 506(b) | Form D ↗ |
| Sep 28, 2018 | Oct 18, 2018 | $2,525,000of $4.0M target | 5 | $505K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $57,228,445 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by Othram
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Sep 16, 2021 | Series B | $18 million | Gigafund (lead) | Othram Series B announcement ↗ |
Why Investors Backed Othram
Othram sells forensic identification services and software to law enforcement. Its integrated system joins laboratory DNA testing, family-tree analysis and case workflows. The product is built for samples that traditional tests often cannot use. It can turn those samples into investigative leads while keeping the work in one pipeline.
The problem it targets
At least 250,000 murders remain unsolved in the United States. There may also be 50,000 to 75,000 unidentified human remains. More than half of sexual-assault kits do not identify an assailant through CODIS, the existing forensic DNA framework. CODIS often cannot identify remains because victims are usually absent from its records. Old evidence may be degraded, contaminated with bacteria or contain very little human DNA. These gaps consume resources for agencies with limited budgets.
What the product does
Using massively parallel sequencing, Othram reads many DNA fragments at once to recover profiles from damaged or scant forensic samples. Its platform combines testing, family-tree analysis and evidence review in one operating process. The lab has identified people from century-old bones, touch DNA and hair without roots. The platform also includes hardware designed for deployment. Its relationship software ranks likely positions for an unknown person in a family tree. Other tools trace common ancestors and search branches for surname links.
Progress so far
By 2024, Othram had won one Phase I and one Phase II small-business research award, totaling $1,324,769. The larger award funded genome-wide analysis of forensic evidence, while the earlier project focused on digitizing difficult DNA. The work addressed Air Force and Defense Department needs involving missing service members. During the three years before its 2021 financing, Othram's technology helped local, state and federal agencies crack cases cold for decades. The funding was intended to grow operations across North America.
Who backs it
Gigafund led the Series B, and the financing was set to add Stephen Oskoui to Othram's board. Oskoui said Othram had closed many cold cases and could become standard practice for law enforcement. Former Founders Fund partners Luke Nosek and Oskoui founded Gigafund. The firm then managed more than $1.5 billion. Its investments included SpaceX, the Boring Company and Last Energy.
We wrote this summary from public statements by Othram and its investors. It is not investment advice.
Othram in the News
Leadership Team
Executive officers and directors listed on Othram's Form D filed Nov 6, 2026.
Earlier filings also listed Stephen Hsu (director, last listed Sep 2021).
Sources
- SECOTHRAM, INC. Form D, filed Feb 15, 2024
- SECOTHRAM, INC. filing history
- CompanyOthram mission
- CompanyOthram terms of use
- CompanyOthram pressroom
- PressSorenson Forensics acquisition
- PressOthram Studios launch
- PressAmerica's Crime Lab launch
- ResearchFederal SBIR portfolio
- ResearchOthram Maps research article